Understanding the functions of the BRCA protein complexes in DNA break repair and in replication stress

Informazioni relative al progetto

BRCA INSIGHTS

ID dell’accordo di sovvenzione: 101018257

DOI

10.3030/101018257

Data della firma CE 3 Giugno 2021

Data di avvio 1 Aprile 2022

Data di completamento 31 Marzo 2027

Finanziato da

• EXCELLENT SCIENCE - European Research Council (ERC)

Costo totale

€ 1 868 152,50

Contributo UE

€ 1 868 152,50

Coordinato da

FONDAZIONE PER L'ISTITUTO DI RICERCA IN BIOMEDICINA
Switzerland

Periodic Reporting for period 2 - BRCA INSIGHTS (Understanding the functions of the BRCA protein complexes in DNA break repair and in replication stress)

Periodo di rendicontazione: 2023-10-01 al 2025-03-31

Sintesi del contesto e degli obiettivi generali del progetto

The BRCA INSIGHTS project aims to uncover the molecular mechanisms by which BRCA1 and BRCA2 proteins contribute to DNA double-strand break (DSB) repair and replication fork stability. These tumor suppressor proteins are frequently mutated in familial and sporadic breast and ovarian cancers. While their canonical role in DSB repair through homologous recombination is established, their emerging non-canonical roles in replication fork protection and remodeling under stress remain poorly understood. This project employs advanced biochemical techniques to define the precise functions of BRCA proteins in these processes, leveraging state-of-the-art protein purification and controlled experimental systems.

Understanding how BRCA1 and BRCA2 function to maintain genome stability addresses critical gaps in cancer biology. Insights from this research have the potential to influence cancer treatment by improving the understanding of chemoresistance mechanisms in BRCA-mutated tumors and identifying new therapeutic targets. By advancing basic knowledge, the project ultimately aligns with the goals of reducing cancer burden and improving cancer therapy through precision medicine.

Lavoro eseguito dall’inizio del progetto fino alla fine del periodo coperto dalla relazione e principali risultati finora ottenuti

We explored how cells repair DNA damage, particularly DNA double-strand breaks (DSBs). DNA break repair is essential for preventing mutations that can lead to diseases such as cancer. Our research focused on a specific protein complex called BRCA1–BARD1, which is widely known for its role in suppressing breast and ovarian cancers.

We discovered that BRCA1–BARD1 complex plays a crucial role in promoting long-range DNA end resection during homologous recombination. DNA end resection is a critical early step in DSB repair. This process involves the controlled degradation of one strand of DNA at the site of the break to generate a single-stranded DNA (ssDNA) overhang. The ssDNA overhang serves as a platform for the recruitment and binding of proteins required for high-fidelity repair through homologous recombination (HR).

Specifically, the study demonstrates that BRCA1–BARD1 directly stimulates the activities of the nucleases EXO1 and DNA2, along with their associated helicases Werner (WRN) or Bloom (BLM). The BRCA1–BARD1 complex enhances the helicase function, facilitating DNA unwinding required for resection. Additionally, the formation of the BRCA1–C complex, involving phosphorylated CtIP and MRN, further boost the resection process.

Together, our data provided key novel insights the the function of the BRCA1-BRCA2 complex in DNA repair.

Progressi oltre lo stato dell’arte e potenziale impatto previsto (incluso l’impatto socioeconomico e le implicazioni sociali più ampie del progetto fino ad ora)

The results in our first publication surpass the current state of the art by providing a more detailed mechanistic understanding of the role of the BRCA1–BARD1 complex in DNA end resection, a critical step in DNA double-strand break (DSB) repair. Moving forward, we will focus also on the role of BRCA2, and study how the protein function in DNA break repair and how they support DNA replication.

A cartoon showing the function of the BRCA1-BARD1 complex in DNA end resection